Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail

0

23.04.2024 17:44

Fiercebiotech.com

Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail gmasson Tue, 04/23/2024 - 10:44

СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *